Table 2A. Comparison of training and validation patients without recurrence.
Non-Recurrence (N = 101) | Training (N = 73) | Validation (N = 28) |
---|---|---|
Age, years (median ± SD) | 62.0 ± 10.6 | 68.5 ± 15.5 |
Follow-up, months (median ± SD) | 56.8 ± 12.1 | 55.9 ± 12.2 |
Sex, number (%) | ||
Male | 36 (49.3) | 15 (53.6) |
Female | 37 (50.7) | 13 (46.4) |
Stage, number (%) | ||
IA | 41 (56.2) | 9 (32.1) |
IB | 30 (41.1) | 18 (64.3) |
IIA | 1 (1.4) | 0 (0.0) |
IIB | 1 (1.4) | 0 (0.0) |
IIIA | 0 (0.0) | 1 (3.6) |
SD, standard deviation.